Orientations

Frequently Asked Questions (FAQ) on use of fractional dosing with intradermal administration of mpox MVA-BN vaccine in the context of vaccine supply-constrained outbreak response

World Health Organization (WHO)

This document outlines key considerations for the use of fractional dosing with intradermal administration of the MVA-BN mpox vaccine in response to ongoing mpox outbreaks. In light of the limited availability of vaccine and current WHO recommendations, national authorities may, as a temporary outbreak response measure, consider administering MVA-BN vaccine via intradermal injection at a reduced dose to protect individuals at risk of exposure.

Auteurs

Langues

  • Anglais

Année de publication

2025

Type

Orientations

Catégories

  • Vaccins et dispositifs d'administration

Maladies

  • Mpox

Organisations

  • Organisation Mondiale de la Santé (OMS)

Mots-clés

  • Urgences
  • Épidémie
  • Gestion de vaccin
  • Approvisionnement en vaccins

Régions de l'OMS

  • Région africaine

Mpox-Policy

Vous pouvez trouver plus d’informations sur "Mpox-Policy" dans les rubriques suivantes :

TitreAuteurAnnéeTypeLangue
Smallpox and mpox (orthopoxviruses): WHO position paperWorld Health Organization (WHO)2024GuidanceAnglais, Français
Summary of WHO SAGE recommendations for mpox vaccines, including considerations for off-label useWorld Health Organization (WHO)2025PresentationAnglais
Off-label vaccine use: explanatory note for countriesWorld Health Organization (WHO)2024GuidanceAnglais
MVA-BN (‎Modified Vaccinia Ankara – Bavarian Nordic)‎ smallpox and mpox vaccine: Interim guidanceWorld Health Organization (WHO)2024GuidanceAnglais, Français
ETF statement on the use of Imvanex for the prevention of mpox in children below 12 years of ageEuropean Medicines Agency2024GuidanceAnglais
Regulatory & Policy Considerations for Mpox Vaccines in African CountriesWorld Health Organization (WHO), European Medicines Agency, Bavarian Nordic2025PresentationAnglais
LC16m8 (live-attenuated freeze-dried vaccinia) smallpox and mpox vaccine - Interim GuidanceWorld Health Organization (WHO)2025GuidanceAnglais, Français
Frequently Asked Questions (FAQ) on use of fractional dosing with intradermal administration of mpox MVA-BN vaccine in the context of vaccine supply-constrained outbreak responseWorld Health Organization (WHO)2025GuidanceAnglais

Ajouté par: Miluka Gunaratna

Ajouté le: 2025-06-25 10:57:02

Consultations: 1088

Liens

Fichier téléchargé

WHO_FAQ_Intradermal fractional dosing_MVA-BN vaccine_v190625 Final.pdf

Cliquez pour télécharger

Ajouter une ressource